Caroline Bailey, age 54, experienced severe abdominal pain beginning in March that she initially believed was caused by her contraceptive coil. When she sought medical attention to have it removed, healthcare providers were unable to address her concerns immediately, and she reported frustration with the time it took to be taken seriously regarding her symptoms.
Medical evaluation eventually included a CA125 blood test, which returned a reading of 72 units per ml. According to Ovarian Cancer Action, readings above 35 U/ml warrant further investigation for women over 40. Subsequent imaging and biopsy revealed a 13cm tumor and confirmed a diagnosis of stage three ovarian cancer that had spread to the omentum, a fatty tissue near the womb and ovaries. Bailey was initially concerned about her prognosis upon learning the tumor size.
Treatment began with four rounds of chemotherapy at The Christie in Manchester, which reduced the tumor to 8cm. In October, she underwent a six-hour surgical procedure involving total hysterectomy, removal of the omentum, and appendectomy. Following surgery, she received two additional chemotherapy rounds in January 2024. She now has no evidence of disease, though she was informed that ovarian cancer carries unpredictability and high recurrence risk. Genetic testing revealed mutations increasing her breast and ovarian cancer risk, prompting her to pursue consultations about preventative double mastectomy as part of a clinical trial, and her family members are undergoing genetic testing.
Bailey has advocated for women to seek evaluation of unusual symptoms and to push for their medical concerns to be addressed. She experienced significant life disruption during treatment, including job loss and housing instability. According to Cancer Research UK, ovarian cancer represents the 16th most common cancer with approximately 7,700 new cases yearly. Recent Welsh government data indicated that only 51.3% of women initiated first definitive treatment within 62 days of suspected gynaecological cancer, falling below the 75% target.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI